Geographic Information Systems (GIS), and real-time locational data, is emerging as a critical capability in pharmaceutical and biotechnology supply chains. In an industry characterized by complex, global networks of active pharmaceutical ingredients (APIs), biologics, and finished dosage forms (FDFs), the integration of GI enables enhanced visibility, strategic risk assessment, and operational resilience. This white paper presents an in-depth analysis of GI applications, highlights internal and external intelligence use cases, and outlines a framework for integrating geospatial intelligence into pharma and biotech operations. It emphasizes regulatory, logistical, and geopolitical considerations, illustrating how GI transforms strategic decision-making and supply chain resilience.
Introduction: Pharmaceutical and biotech supply chains are inherently global and complex, traversing multiple regions with diverse regulatory environments, infrastructure capabilities, and geopolitical conditions. The concentration of API manufacturing in specific geographies, such as India and China, introduces systemic vulnerabilities to regional disruptions, whether geopolitical, environmental, or infrastructural (National Academies of Sciences, 2022)[1]. Geographical intelligence provides organizations with the tools to visualize spatial dependencies, monitor the movement of sensitive products, and assess risks across multiple tiers of their supply network. Unlike traditional logistics monitoring, GI combines spatial analytics, real-time telemetry, and risk intelligence to inform strategic decisions that directly impact product quality, compliance, and continuity of supply.
Theoretical Foundations and Literature Review: Geographical intelligence in pharmaceutical and biotech contexts extends the concepts of GIS from traditional commercial and environmental applications into highly regulated supply chains. According to Tsakiridi (2021)[2], GIS has proven essential for network optimization, supplier selection, and facility location design, emphasizing its role in mitigating operational risk. The application of GIS in maritime and port operations has been widely documented, demonstrating its utility in route optimization, congestion analysis, and risk forecasting (Isbaex et al., 2025)[3]. In pharmaceutical supply chains, these geospatial tools must additionally account for product-specific requirements, including cold-chain integrity, temperature sensitivity, and regulatory compliance.
The literature highlights the intersection of geographic concentration risk and resilience in pharma. Gao (2024)[4] identifies geopolitical, environmental, and operational risk factors in maritime shipping that can disrupt the flow of critical APIs and biologics. Chen et al. (2023)[5] employ GIS to analyze spatiotemporal patterns of piracy and other maritime hazards, illustrating how geospatial risk mapping informs route planning and threat mitigation.
Applied Geographical Intelligence in Pharma and Biotech: Within pharmaceutical organizations, GI facilitates comprehensive mapping of manufacturing sites, contract manufacturing organizations (CMOs), and distribution hubs, allowing visualization of network dependencies and single points of failure. Cold-chain products, such as monoclonal antibodies and vaccines, require real-time monitoring of both location and temperature. Integrating IoT sensors with GI dashboards provides continuous visibility and alerts, enabling preemptive interventions to maintain product integrity (Maersk, 2024)[6].
Externally, GI supports supplier risk assessment, geopolitical diversification, and security analysis. Mapping API suppliers, CDMOs, and logistics partners allows firms to assess exposure to regional disruptions, regulatory shifts, and infrastructure limitations (Pharmaphorum, 2023)[7]. Integration with blockchain-based provenance systems ensures traceability and mitigates the risk of counterfeiting or diversion (Arxiv, 2022)[8]. These applications demonstrate the strategic value of GI for operational optimization, regulatory compliance, security, and business continuity.
Conceptual Framework for Integration: A four-layer architecture supports the systematic integration of GI into pharmaceutical and biotech supply chains. The data and intelligence layer aggregates IoT telemetry, AIS vessel tracking, regulatory and supplier data, and environmental information. The analytics and modeling layer applies spatial analysis, predictive modeling, and multi-objective optimization to forecast risk and optimize routing and inventory strategies. The decision support and operationalization layer translates analytics into actionable insights through dashboards, scenario simulations, and collaborative planning. The governance and resilience layer ensures data integrity, regulatory alignment, and operational continuity through robust policies and performance metrics (Ioanid et al., 2024)[9].
Challenges and Considerations: Integrating GI into pharmaceutical supply chains presents challenges. Data interoperability across diverse systems and partners is critical yet often deficient. Cybersecurity is a concern as GPS and IoT-enabled GI systems are vulnerable to spoofing or tampering. Regulatory compliance adds complexity, particularly in GDP and cold-chain contexts, where geospatial decisions must align with quality standards. High computational demands and the need for specialized expertise may limit scalability. Ethical considerations, including data privacy and sharing, must ensure corporate and legal compliance (Wattanakul et al., 2018)[10].
Strategic Implications: Geographical intelligence should be recognized as a strategic asset in pharmaceutical and biotech supply chains. Organizations can leverage GI to diversify supply networks, enhance cold-chain monitoring, improve visibility across multi-tiered suppliers, and integrate scenario-based resilience planning. Collaboration with logistics partners, regulatory bodies, and technology providers maximizes GI benefits while mitigating risks. Policymakers can facilitate resilience by encouraging geographic diversification and transparency within the pharmaceutical supply ecosystem (Cambridge, 2023)[11].
Conclusion: Geographical intelligence transforms pharmaceutical and biotech supply chain management by integrating spatial analysis with operational, regulatory, and risk intelligence. By providing visibility into the location, condition, and interdependencies of critical supply chain assets, GI enables organizations to proactively manage disruptions, optimize logistics, and enhance resilience. As global supply chain risks evolve, GI will become increasingly central to strategic planning, operational execution, and competitive differentiation in the pharmaceutical and biotechnology sectors.
References: [1] National Academies of Sciences, Engineering, and Medicine. The Globalization of U.S. Medical Product Supply Chains: Risks and Opportunities. National Academies Press, 2022. [2] Tsakiridi, A. Applications of Geographic Information Systems (GIS) in Supply Chain Management: Systematic Literature Review. International Journal of Supply Chain Management, 10(5), 2021. [3] Isbaex, C., Costa, F. R. F., & Batista, T. Application of GIS in the Maritime-Port Sector: A Systematic Review. Sustainability, 17(8), 3386, 2025. [4] Gao, Y. Analysis of Risk Factors for Disruptions in International Maritime Shipping Supply Chains. Frontiers in Business, Economics and Management, 17(2), 2024. [5] Chen, Q., Zhang, H., Lau, Y.-y., et al. A GIS-Based Investigation of Spatiotemporal Characteristics of Pirate Attacks in the Maritime Industry. Journal of Marine Science and Engineering, 11(12), 2295, 2023. [6] Maersk. The Importance of Visibility for Pharma Supply Chains. Maersk Insights, 2024. [7] Pharmaphorum. Pharma Must Map Its Supply Chains to Manage Risks and Rewards of Emerging Markets. 2023. [8] Arxiv. Blockchain Applications for Pharmaceutical Supply Chain Security. 2022. [9] Ioanid, A., Scarlat, C., & Andrei, N. Artificial Intelligence and Geospatial Technologies for Sustainable Maritime Logistics: Case Study — Port of Constanta, Romania. MARLOG, 2024. [10] Wattanakul, S., Henry, S., Bentaha, M. L., et al. Improving Risk Management by Using Smart Containers for Real-Time Traceability. arXiv, 2018. [11] Cambridge.org. Geography of Health: Onshoring Pharmaceutical Manufacturing to Address Supply Chain Challenges. World Trade Review, 2023.